PharMEDium Recalls Morphine and Bupivacaine Bags Due to Glass Particulate
PharMEDium Services is recalling 80 bags of compounded morphine and bupivacaine injectable solution due to the presence of glass particulate matter.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of glass particulate in a sterile injectable drug poses a significant risk of injury, meeting the criteria for a Severe rating.
Plain-English summary
PharMEDium Services, LLC is recalling 80 bags of 0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI (Preservative Free) in 0.9% Sodium Chloride, 250 mL Hospira LifeCare bags. The product is a prescription-only sterile injectable drug compounded in Memphis, Tennessee, and was distributed nationwide.
The recall was initiated because the active pharmaceutical ingredient (API) used to produce the sterile injectable drugs was contaminated with glass particulate matter. The affected lots include specific expiration dates ranging from May 2016 to July 2016.
Healthcare providers and patients should stop using the affected product immediately. Consumers should contact their healthcare provider for guidance on alternative treatments or further instructions regarding the recalled medication.
The recalled product
- Product
- 0.05 mg/mL Morphine Sulfate and 0.0625% Bupivacaine HCI (Preservative Free) in 0.9% Sodium Chloride, 250 mL Hospira LifeCare bag, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-995-54 ,
- Manufacturer
- Pharmedium Services, LLC
- Category
- Drug — Injectable
- Affected units
- 80
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot # 160420165M
- Exp. 05/16 Lot # 160540128M
- Exp. 05/16 Lot # 160630117M
- Exp. 06/16 Lot # 160770157M
- Exp. 06/16 Lot # 160870055M
- Exp. 06/16 Lot # 160890153M
- Exp. 06/16 Lot # 160950340M
- Exp. 07/16
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 75 recalled by Pharmedium Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 75 products in this recall →Related recalls
Same manufacturer · Pharmedium Services, LLC
See all →- SeverePharMEDium Recalls ePHEDrine Sulfate Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls nICARdipine HCl Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Rocuronium Bromide Syringes Due to Sterility Assurance Issues
FDA (Drugs) · 2020-04-15
- SeverePharMEDium Recalls Fentanyl Citrate Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2020-04-15
Same hazard · glass particulate
See all →- SevereTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighTestosterone Pellet 200 mg Recalled for Glass Particulate Matter
FDA (Drugs) · 2025-05-14
- HighProgesterone Injection Recalled for Glass Particulate Matter in Vials
FDA (Drugs) · 2024-08-07
- HighCyanocobalamin Injection Vials Recalled for Glass Particulate Contamination
FDA (Drugs) · 2024-07-24
- HighEye and Ear Dropper Recalled for Potential Glass Particulate Contamination
FDA (Devices) · 2023-06-21